Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block with Bupivacaine and Magnesium Sulfate for PHN
NCT04546334Completed
- Sponsor
- Tanta University
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine and magnesium sulfate in postherpetic neuralgia (PHN) (3 arms), sponsored by Tanta University. Primary endpoint: Efficacy of pain relief at 3 months. Started Sep 2020; status: completed.
02
Drugs
bupivacainemagnesium sulfate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT04546334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04546334.